Verbatim response from ChatGPT
Short answer
- If your main goal is the largest average weight loss and you don’t have specific contraindications, ask your clinician about tirzepatide (Zepbound) — clinical trials have shown greater mean weight loss than semaglutide.
- If you prefer a drug with a longer availability history in obesity care or your clinician thinks semaglutide suits you better, ask about Wegovy (semaglutide).
Either way, you need a prescription and medical evaluation first.
Key differences to discuss with your clinician
- Mechanism/efficacy: Zepbound (tirzepatide) is a dual GIP/GLP-1 receptor agonist and generally produced larger average weight losses in head-to-head and separate trials than semaglutide (Wegovy), which is a GLP-1 receptor agonist.
- Side effects: Both commonly cause GI effects (nausea, vomiting, diarrhea, constipation). Side-effect profiles and tolerability vary person to person.
- Safety considerations: Both carry warnings from rodent studies about thyroid C‑cell tumors; they are generally contraindicated if you or a close relative have medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2). Discuss pancreatitis history, pregnancy plans, gallbladder disease, and other meds with your clinician.
- Experience and coverage: Wegovy (semaglutide) has been in obesity care longer and may be more familiar to some clinicians/payers. Payer coverage varies widely for both drugs.
Where to get them online (legitimately)
- Start with your primary care doctor or an endocrinologist — they can evaluate you and write a valid prescription.
- Manufacturer resources and patient support programs:
- Wegovy (Novo Nordisk) — Novo Nordisk offers patient support and savings resources.
- Zepbound (Eli Lilly) — Eli Lilly offers patient assistance and support information.
- Telehealth clinics that provide evaluation and prescriptions for GLP‑1/tirzepatide therapy:
- Calibrate (structured weight‑loss program with coaching)
- PlushCare
- Ro / Roman
- Hims & Hers
- Lemonaid Health
(Each offers virtual visits and prescriptions when appropriate — services and drugs offered vary, so confirm before signing up.)
- Filling the prescription:
- Large retail pharmacies (CVS, Walgreens, Walmart) and most independent pharmacies will fill Wegovy or Zepbound with a prescription.
- Some prescriptions are dispensed via specialty/mail-order pharmacies that handle injectables (e.g., Optum Specialty, Accredo, Diplomat) — your prescriber or insurer will tell you if that’s required.
- Avoid: buying injectable GLP‑1 drugs from unverified online marketplaces, social‑media sellers, overseas pharmacies without prescriptions, or “peptide” shops — these can be counterfeit, unsafe, or illegal.
Insurance and cost tips
- Coverage varies widely. Many insurers require preauthorization and have specific criteria (BMI, comorbidities). Zepbound and Wegovy may be covered differently.
- Check with your insurer before starting and ask your prescriber to submit prior authorization if needed.
- Both manufacturers offer patient savings or copay support programs; ask the manufacturer’s support team about eligibility.
What to do next
- Book an appointment with your PCP or an endocrinologist and discuss your weight, goals, medical history, and pregnancy plans. Say you’re interested in either Wegovy (semaglutide) or Zepbound (tirzepatide) and want their recommendation.
- If you prefer online care, pick one reputable telehealth service above and confirm they prescribe the specific medication you want.
- If you want, tell me whether you have diabetes, your approximate BMI, any relevant medical history (thyroid cancer in family, pancreatitis, pregnancy plans), and whether you have insurance — I can give more tailored guidance and point to specific telehealth options that commonly prescribe these drugs.
Would you like help finding telehealth clinics that operate in your state or checking coverage questions next?